The SW-982 cell line was initiated by A. Leibovitz in 1974 at the Scott and White Clinic, Temple, Texas from a surgical specimen of a biphasic synovial sarcoma removed from a 25 year old female Caucasian. The histopathology evaluation reported an undifferentiated malignant tumor consistent with liposarcoma.